New Hybrid Medicine Agilus Developed for Malignant Hyperthermia

Health Nachrichten

New Hybrid Medicine Agilus Developed for Malignant Hyperthermia
Malignant HyperthermiaHybrid MedicineAgilus
  • 📰 Medscape
  • ⏱ Reading Time:
  • 22 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 29%
  • Publisher: 55%

Agilus, a new hybrid medicine, has been developed for the treatment of malignant hyperthermia, a rare disorder that causes overstimulation of skeletal muscles. It contains the same active substances as Dantrolen IV 20 mg but with improved formulation for easier use.

Malignant hyperthermia is a rare disorder in which skeletal muscles are overstimulated and unable to relax. Sudden onset can be triggered by, or occasionally by stresses such as vigorous exercise or heat. Malignant hyperthermia can be life-threatening because it causes a rapid rise in body temperature and/or metabolic acidosis. Agilus is a hybrid medicine of muscle relaxant dantrolene sodium (Dantrolen IV 20 mg), which has been authorized in the European Union since 1984.

It works by binding to the ryanodine receptor 1, preventing release of calcium from the sarcoplasmic reticulum. Agilus contains the same active substances as Dantrolen IV 20 mg but will be available in a 120-mg powder for solution for injection. In the formulation of Agilus, theand sodium hydroxide have been replaced with hydroxypropyl-beta-cyclodextrin and Macrogol 3350 to shorten the preparation time and improve ease of us

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

Medscape /  🏆 386. in US

Malignant Hyperthermia Hybrid Medicine Agilus Skeletal Muscles Dantrolene Sodium

Österreich Neuesten Nachrichten, Österreich Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Mercedes-AMG E53 Hybrid: A Powerful Plug-In Hybrid with Impressive RangeMercedes-AMG E53 Hybrid: A Powerful Plug-In Hybrid with Impressive RangeThe new Mercedes-AMG E53 Hybrid is a plug-in hybrid car capable of delivering up to 612hp and up to 62 miles of pure electric range. This announcement comes at a time when car makers are realizing that the transition to full electrification will be slower and more gradual than previously thought. The E53 Hybrid is seen as a significant step towards answering the challenges of electric mobility. The car features a 3.0-litre twin-turbocharged petrol straight-six engine that produces 443hp, along with a 161hp electric motor.
Weiterlesen »

Saint Louis, Missouri job with Washington University School of Medicine Department of MedicineSaint Louis, Missouri job with Washington University School of Medicine Department of MedicineJob Description Our laboratory at the Washington University in St. Louis is seeking a postdoctoral experimental biologist to join our interdisciplinary team studying urogenital diseases and cancer. Our team combines experimentation and computational analyses to advance precision medicine.
Weiterlesen »

New data shows asthma medicine may help reduce severe food allergy reactionsNew data shows asthma medicine may help reduce severe food allergy reactionsA new study finds that the asthma medication Xolair may substantially reduce severe allergic reactions in people who have multiple food allergies.
Weiterlesen »

MG 3 reinvented with bold new look and hybrid powerMG 3 reinvented with bold new look and hybrid powerChinese brand's all-new supermini claims 64mpg and quickest acceleration in class for around £20,000
Weiterlesen »

Karma to offer updated Revero hybrid alongside new EVsKarma to offer updated Revero hybrid alongside new EVsKarma is jumping on the EV bandwagon but will continue to offer a series plug-in hybrid for buyers who prefer the convenience of filling at a gas station.
Weiterlesen »



Render Time: 2025-03-11 21:53:49